Hormel Foods
HRL
19.55
-0.33
-1.66%
Hormel Foods
US · HRL
#1372 by market cap
Listed 1970
19.55
-0.33
-1.66%
Live - 5344 symbols - heartbeat 88s ago
· 2026-10-08 08:35
Pre-market
19.55
0.00%
After-hours
19.68
+0.68%
Overnight
19.56
+0.05%
- Market cap
- 10.76B
- P/E (TTM)i
- 31.53
- P/Bi
- 1.37
- EPSi
- 0.87
- Div yieldi
- 5.97%
- 52W posi
- 2%
Reader sentiment
Are you bullish or bearish on HRL?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.27, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.56% YoY
Margins
- Gross margin
- 15.63%
- Operating margin
- 7.39%
- Net margin
- 3.95%
Key ratios & quality
- Enterprise valuei
- 12.91B
- Altman Z-Scorei
- 3.27
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.55B | 9.50B | 9.61B | 11.39B | 12.46B | 12.11B | 11.92B | 12.11B |
| Gross profit | 1.98B | 1.88B | 1.83B | 1.93B | 2.16B | 2.00B | 2.02B | 1.89B |
| Selling & admin expenses | 841.21M | 727.58M | 761.32M | 853.07M | 879.27M | 942.17M | 1.01B | 996.62M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.14B | 1.16B | 1.06B | 1.07B | 1.29B | 1.06B | 1.02B | 895.19M |
| Pretax profit | 1.18B | 1.21B | 1.11B | 1.13B | 1.28B | 1.01B | 1.04B | 663.45M |
| Tax | 168.70M | 230.57M | 206.39M | 217.03M | 277.88M | 220.55M | 230.80M | 185.68M |
| Net profit | 1.01B | 979.15M | 908.35M | 909.14M | 1.00B | 792.92M | 804.63M | 477.76M |
| Basic EPS | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Diluted EPS | 1.86 | 1.80 | 1.66 | 1.66 | 1.82 | 1.45 | 1.47 | 0.87 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 2.90B | 3.03B | 3.19B | 3.03B | 2.97B | 2.96B |
| Gross profit | 484.43M | 487.31M | 444.84M | 469.58M | 518.51M | 471.52M |
| Selling & admin expenses | 251.43M | 258.71M | 223.47M | 241.70M | 318.62M | 323.50M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 233.00M | 228.60M | 221.38M | 227.88M | 199.88M | 148.01M |
| Pretax profit | 230.49M | 236.51M | -21.63M | 234.31M | 206.06M | 103.16M |
| Tax | 50.75M | 52.82M | 34.58M | 52.54M | 48.69M | 43.64M |
| Net profit | 179.74M | 183.70M | -56.20M | 181.77M | 157.38M | 59.52M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.33 | 0.33 | -0.10 | 0.33 | 0.29 | 0.11 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.05B | 2.36B | 3.58B | 2.95B | 3.64B | 3.30B | 3.25B | 3.41B |
| Cash & ST investments | 459.14M | 687.64M | 1.73B | 634.69M | 998.26M | 753.20M | 766.62M | 703.59M |
| Inventory | 963.53M | 1.04B | 1.07B | 1.37B | 1.72B | 1.68B | 1.58B | 1.75B |
| Total assets | 8.14B | 8.11B | 9.91B | 12.70B | 13.31B | 13.45B | 13.43B | 13.39B |
| Total current liabilities | 1.14B | 1.11B | 1.50B | 1.42B | 1.47B | 2.31B | 1.40B | 1.38B |
| Short-term debt | -- | -- | 258.69M | 8.76M | 8.80M | 950.53M | 7.81M | 6.65M |
| Long-term debt | 624.84M | 250.00M | 1.04B | 3.32B | 3.29B | 2.36B | 2.85B | 2.85B |
| Total liabilities | 2,537,474,000.00 | 2,183,469,000.00 | 3,477,956,000.00 | 5,717,968,000.00 | 5,766,699,000.00 | 5,709,787,000.00 | 5,430,719,000.00 | 5,477,304,000.00 |
| Total equity | 5.60B | 5.93B | 6.43B | 6.98B | 7.54B | 7.74B | 8.00B | 7.92B |
| Retained earnings | 5.73B | 6.13B | 6.52B | 6.88B | 7.31B | 7.49B | 7.68B | 7.52B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 3.28B | 3.32B | 3.41B | 3.39B | 3.49B | 3.53B |
| Cash & ST investments | 698.98M | 630.67M | 703.59M | 901.21M | 859.86M | 868.45M |
| Inventory | 1.73B | 1.82B | 1.75B | 1.65B | 1.75B | 1.80B |
| Total assets | 13.42B | 13.50B | 13.39B | 13.32B | 13.34B | 13.29B |
| Total current liabilities | 1.33B | 1.35B | 1.38B | 1.27B | 1.80B | 1.87B |
| Short-term debt | 7.25M | 6.74M | 6.65M | 6.49M | 505.34M | 505.63M |
| Long-term debt | 2.85B | 2.85B | 2.85B | 2.85B | 2.35B | 2.35B |
| Total liabilities | 5,379,867,000.00 | 5,403,634,000.00 | 5,477,304,000.00 | 5,363,226,000.00 | 5,380,410,000.00 | 5,432,360,000.00 |
| Total equity | 8.04B | 8.09B | 7.92B | 7.95B | 7.96B | 7.86B |
| Retained earnings | 7.71B | 7.73B | 7.52B | 7.54B | 7.53B | 7.43B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.24B | 923.00M | 1.13B | 1.00B | 1.13B | 1.05B | 1.27B | 845.25M |
| Depreciation & amortization | 161.86M | 165.21M | 205.78M | 209.31M | 235.89M | 253.31M | 257.76M | 263.90M |
| Free cash flow | 852.12M | 629.16M | 760.52M | 769.52M | 856.06M | 777.64M | 1.01B | 534.35M |
| Dividends paid | -388.11M | -437.05M | -487.38M | -523.11M | -557.84M | -592.93M | -614.96M | -633.19M |
| Stock buybacks / issuance | -46.90M | -174.25M | -12.36M | -19.96M | 0 | -12.30M | 0 | 0 |
| Ending cash balance | 459.14M | 672.90M | 1.71B | 613.53M | 982.11M | 736.53M | 741.88M | 670.68M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 56.44M | 156.70M | 322.91M | 349.21M | 178.94M | 240.60M |
| Depreciation & amortization | 63.96M | 64.69M | 69.37M | 67.10M | 68.83M | 66.43M |
| Free cash flow | -18.64M | 84.51M | 231.45M | 280.22M | 96.77M | 172.44M |
| Dividends paid | -159.25M | -159.47M | -159.50M | -159.50M | -160.94M | -160.96M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 669.69M | 599.19M | 670.68M | 867.91M | 826.75M | 839.64M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 19.21 | 16.99 | 14.71 | 13.57 | 13.79 | 10.39 | 10.24 | 6.02 |
| ROA %i | 13.39 | 12.05 | 10.08 | 8.04 | 7.69 | 5.93 | 5.99 | 3.56 |
| ROIC %i | 18.00 | 15.62 | 12.66 | 10.05 | 9.72 | 7.67 | 7.58 | 4.78 |
| 5-year avg ROE %i | 18.76 | 18.67 | 18.01 | 16.50 | 15.65 | 13.89 | 12.54 | 10.80 |
| EBIT margin %i | 12.65 | 12.93 | 11.82 | 10.27 | 10.76 | 8.98 | 9.36 | 6.12 |
| FCF / sales %i | 8.93 | 6.62 | 7.92 | 6.76 | 6.87 | 6.42 | 8.48 | 4.41 |
| Current ratioi | 1.80 | 2.14 | 2.38 | 2.08 | 2.47 | 1.43 | 2.32 | 2.47 |
| Quick ratioi | 0.93 | 1.16 | 1.65 | 1.09 | 1.27 | 0.68 | 1.17 | 1.15 |
| Debt / assetsi | 7.67 | 3.08 | 13.16 | 26.18 | 24.79 | 24.61 | 21.28 | 21.34 |
| LT debt / equityi | 11.16 | 4.22 | 16.26 | 47.54 | 43.67 | 30.49 | 35.67 | 36.08 |
| Interest coveragei | 45.59 | 67.95 | 53.91 | 27.00 | 21.44 | 14.81 | 13.80 | 9.50 |
| Revenue CAGR (3Y) %i | 1.00 | -0.09 | 1.58 | 6.05 | 9.47 | 8.02 | 1.54 | -0.95 |
| Net income CAGR (3Y) %i | 13.84 | 3.22 | 2.36 | -3.52 | 0.72 | -4.39 | -3.96 | -21.80 |
| FCF CAGR (3Y) %i | 0.16 | -7.09 | -2.18 | -3.34 | 10.81 | 0.74 | 9.50 | -14.54 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 9.39 | 9.46 | 6.02 | 6.13 | 5.84 | 4.30 |
| ROA %i | 5.43 | 5.67 | 3.56 | 3.66 | 3.49 | 2.56 |
| ROIC %i | 6.99 | 7.30 | 4.78 | 4.88 | 4.67 | 3.49 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 8.67 | 8.65 | 6.12 | 6.24 | 6.01 | 4.95 |
| FCF / sales %i | 5.83 | 5.21 | 4.41 | 4.76 | 5.67 | 6.43 |
| Current ratioi | 2.47 | 2.47 | 2.47 | 2.66 | 1.94 | 1.88 |
| Quick ratioi | 1.12 | 1.07 | 1.15 | 1.30 | 0.93 | 0.89 |
| Debt / assetsi | 21.29 | 21.17 | 21.34 | 21.46 | 21.41 | 21.48 |
| LT debt / equityi | 35.49 | 35.26 | 36.08 | 35.91 | 29.57 | 29.95 |
| Interest coveragei | 12.95 | 13.39 | 9.50 | 9.68 | 9.34 | 7.62 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Perishable is the largest reported line at 73.91% of revenue, across 2 reported segments.
- The next-largest line, Shelf-stable, is a distant second at 26.09% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Perishable73.91%
Shelf-stable26.09%
Quote time 2026-10-08 08:35:25 · For reference only, not investment advice and not tailored to your situation.